{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:33:48Z","timestamp":1760549628748},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejps.2014.09.021","type":"journal-article","created":{"date-parts":[[2014,10,19]],"date-time":"2014-10-19T12:32:14Z","timestamp":1413721934000},"page":"78-82","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy"],"prefix":"10.1016","volume":"66","author":[{"given":"Patr\u00edcia","family":"Severino","sequence":"first","affiliation":[]},{"given":"Marcelo","family":"Szymanski","sequence":"additional","affiliation":[]},{"given":"Marianna","family":"Favaro","sequence":"additional","affiliation":[]},{"given":"Adriano R.","family":"Azzoni","sequence":"additional","affiliation":[]},{"given":"Marco V.","family":"Chaud","sequence":"additional","affiliation":[]},{"given":"Maria Helena A.","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Am\u00e9lia M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.09.021_b0005","first-page":"3","article-title":"Non-viral and viral vectors for gene therapy","volume":"51","author":"Boulaiz","year":"2005","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.ejps.2014.09.021_b0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chemphyslip.2011.12.005","article-title":"Effect of head group and curvature on binding of the antimicrobial peptide tritrpticin to lipid membranes","volume":"165","author":"Bozelli","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2014.09.021_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2014.09.021_b0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/IJN.S27471","article-title":"Influence of charge ratio of liposome\/DNA complexes on their size after extrusion and transfection efficiency","volume":"7","author":"Brgles","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2014.09.021_b0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2012.01.001","article-title":"Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design","volume":"49","author":"Carbone","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2014.09.021_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2014.05.024","article-title":"The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC","volume":"121","author":"Carbone","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2014.09.021_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2013.10.003","article-title":"FA-loaded lipid drug delivery systems: preparation, characterization and biological studies","volume":"52","author":"Carbone","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.09.021_b0040","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.biomaterials.2004.01.031","article-title":"Low toxicity of cationic lipid-based emulsion for gene transfer","volume":"25","author":"Choi","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2014.09.021_b0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejpb.2007.07.011","article-title":"Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells","volume":"68","author":"Choi","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2012.04.014","article-title":"Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors","volume":"431","author":"Cortesi","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2007.03.015","article-title":"Solid lipid nanoparticles: formulation factors affecting cell transfection capacity","volume":"339","author":"del Pozo-Rodriguez","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.08.042","article-title":"Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies","volume":"420","author":"Doktorovova","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejps.2011.12.016","article-title":"Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)","volume":"45","author":"Doktorovova","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.09.021_b0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2013.11.025","article-title":"Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity","volume":"461","author":"Fangueiro","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0075","first-page":"311","article-title":"Classification of surface active agents by HLB","volume":"1","author":"Griffin","year":"1949","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1016\/j.ejps.2014.09.021_b0080","first-page":"249","article-title":"Calculation of HLB valuess of nonionic surfactants","volume":"5","author":"Griffin","year":"1954","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1016\/j.ejps.2014.09.021_b0085","doi-asserted-by":"crossref","DOI":"10.3109\/03639045.2011.645835","article-title":"Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles","author":"Howard","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.colsurfb.2013.10.021","article-title":"Cationic surfactants in the form of nanoparticles and micelles elicit different human neutrophil responses: a toxicological study","volume":"114","author":"Hwang","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2014.09.021_b0095","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/IJN.S30928","article-title":"Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems","volume":"7","author":"Jiang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2014.09.021_b0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/med.20086","article-title":"Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail","volume":"27","author":"Juillerat-Jeanneret","year":"2007","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejps.2014.09.021_b0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.colsurfb.2010.05.026","article-title":"Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery","volume":"79","author":"Liu","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2014.09.021_b0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.colsurfb.2010.05.026","article-title":"Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery","volume":"79","author":"Liu","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2014.09.021_b0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/10717540903047387","article-title":"Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles","volume":"16","author":"Liu","year":"2009","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2014.09.021_b0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0168-3659(01)00506-5","article-title":"Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA","volume":"77","author":"Olbrich","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2014.09.021_b0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.addr.2007.04.004","article-title":"Stability of lipid excipients in solid lipid nanoparticles","volume":"59","author":"Radomska-Soukharev","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2014.09.021_b0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1101\/pdb.prot068122","article-title":"Formation of solid lipid nanoparticle (sln)-gene vector complexe for transfection of mammalian cells in vitro","volume":"2012","author":"Rudolph","year":"2012","journal-title":"Cold Spring Harb Protoc"},{"issue":"3","key":"10.1016\/j.ejps.2014.09.021_b0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10837450.2011.614250","article-title":"Hydrophilic coating of mitotane-loaded lipid nanoparticles: Preliminary studies for mucosal adhesion","volume":"18","author":"Severino","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2014.09.021_b0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.msec.2012.04.017","article-title":"Optimizing SLN and NLC by 22 full factorial design: Effect of homogenization technique","volume":"32","author":"Severino","year":"2012","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2014.09.021_b0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2012.04.050","article-title":"Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI\/ADR-RES)","volume":"431","author":"Siddiqui","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10837450.2012.751401","article-title":"The effect of emulsifying wax on the physical properties of CTAB-based solid lipid nanoparticles (SLN)","volume":"19","author":"Siddiqui","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2014.09.021_b0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i4.10","article-title":"DOTAP (and other cationic lipids): chemistry, biophysics, and transfection","volume":"21","author":"Simberg","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejps.2014.09.021_b0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2003.10.015","article-title":"Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer","volume":"57","author":"Tabatt","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2003.10.015","article-title":"Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer","volume":"57","author":"Tabatt","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1166\/jbn.2012.1383","article-title":"Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin","volume":"8","author":"Taveira","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejps.2014.09.021_b0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2012.01.011","article-title":"Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery","volume":"159","author":"Toledo","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2014.09.021_b0185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2014.09.021_b0190","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2010.01.030","article-title":"PDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles","volume":"389","author":"Vighi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.09.021_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2011.621989","article-title":"The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier","volume":"19","author":"Vighi","year":"2012","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2014.09.021_b0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfb.2012.05.006","article-title":"Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions","volume":"98","author":"Wang","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2014.09.021_b0205","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1002\/jps.23758","article-title":"Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity","volume":"102","author":"Yang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.09.021_b0210","doi-asserted-by":"crossref","first-page":"215102","DOI":"10.1088\/0957-4484\/20\/21\/215102","article-title":"Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery","volume":"20","author":"Yu","year":"2009","journal-title":"Nanotechnology"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T10:10:10Z","timestamp":1565950210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714003789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":41,"alternative-id":["S0928098714003789"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.09.021","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}